Latest News
Conference Coverage
‘Strikingly positive’ effect of novel MS agent
Frexalimab is a novel second-generation monoclonal antibody designed to block the costimulatory CD40/CD40L cellular pathway.
Conference Coverage
MS relapse rates similar between anti-CD20 mAbs and switching to fumarates
Although overall health care encounters did not statistically differ between patients who switched from anti-CD20 monoclonal antibodies to...
From the Journals
Cognitive decline risk in adult childhood cancer survivors
“We need to educate oncologists and primary care providers on the risks our survivors face long after completion of therapy.”
Feature
Is ChatGPT a friend or foe of medical publishing?
Experts agree that the use of AI tools is here to stay. “This is going to become a common tool. I don’t think there’s a way out of that at this...
Conference Coverage
Regular, optimal sleep tied to lower mortality risk
“If sleep were an 8-hour pill, it would be beneficial to take the full dose at regular times consistently.”
From the Journals
Muscle fat: A new risk factor for cognitive decline?
“Increasing adiposity – or fat deposition – in skeletal muscles predicted faster cognitive decline, irrespective of demographics or other disease...
Conference Coverage
Shingles infection rates higher in patients with MS
Even among patients with MS who had no baseline immunosuppression from therapy, rates of herpes zoster infection were significantly higher than...
Conference Coverage
More support for thrombectomy in large-core strokes: TESLA, MAGNA
“Noncontrast CT scans are available at all stroke centers so this study is more practical, highly generalizable, and more applicable globally.”
Conference Coverage
Ozanimod for relapsing MS shows long-term safety, efficacy with age differences
Urinary tract infections and other treatment-emergent adverse events increased with age, but respiratory infections were more common among...
Feature
When could you be sued for AI malpractice? You’re likely using it now
A record that clearly outlines how the physician incorporated the AI is critical if a claim later arises in which the doctor is accused of AI-...
Latest News
Blood biomarker may help predict who will develop Alzheimer’s
At this point, the biomarker is a research tool, but its application in clinical practice “is not very far away.”